phase readout
saveNCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
COMPLETEDupdated 22h ago
community read0 votes
Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Venous Thromboembolism
view source ↗
comments(0)
5-min edit window · permanent after that